Skip to content
ppharmaranks
Menu

Best treatments for hypoparathyroidism

4 products may treat hypoparathyroidism, spanning FDA drug classes such as parathyroid hormone analog, provitamin d2 compound, vitamin d3 analog. The current highest-rated option is bonsity. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 4 drugs we list for hypoparathyroidism, 2 are available as lower-cost generics, spanning classes such as parathyroid hormone analog, provitamin d2 compound, vitamin d3 analog. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for hypoparathyroidism — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate
Treatments we list for hypoparathyroidism
#DrugRatingPharmacy pays
170/100$540View →
2Not yet rated$3View →
3Not yet ratedView →
4Not yet ratedView →

Full ranking · 4 treatments

Frequently asked

What treats hypoparathyroidism?
Our catalog lists 4 products that may treat hypoparathyroidism, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is bonsity.
What is the best-rated treatment for hypoparathyroidism?
By our independent recall-safety rating — not an efficacy measure — bonsity ranks highest among the products we list for hypoparathyroidism. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat hypoparathyroidism?
Treatments for hypoparathyroidism span FDA drug classes including parathyroid hormone analog, provitamin d2 compound, vitamin d3 analog. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.